ReviewOrphanet journal of rare diseases2017

mTOR inhibitors in the pharmacologic management of tuberous sclerosis complex and their potential role in other rare neurodevelopmental disorders.

David N Franz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.